News

Attorneys

Practice Areas

Print PDF

3 Things To Watch After Sandoz's Biosimilars Win

March 20, 2015
Law360

Partner Andrew Ryan comments in Law360's March 20, 2015 article on Amgen Inc. v Sandoz Inc., "3 Things To Watch After Sandoz's Biosimilars Win."

Ryan is a litigator at Cantor Colburn and a member of the firm's Pharmaceutical IP Services Practice Group.

Law360

View Document(s):